ConductScience.org, home

Paper32106643

Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer.

Han MR and 6 others. Cancer Res Treat, 2020. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer. Papers, record 32106643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32106643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer.
PubMed
Journal
Cancer Res Treat
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.78
iCite
Revised in PubMed
2022-04-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Han MRMi-Ryung
2Lee SHSug Hyung
3Park JYJung Yoon
4Hong HHyosun
5Ho JYJung Yoon
6Hur SYSoo Young
7Choi YJYoun Jin

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AscitesMajor topic
Biomarkers, TumorMajor topic
Circulating Tumor DNAMajor topic
MutationMajor topic
Neoplasm Recurrence, LocalMajor topic
Ovarian NeoplasmsMajor topic
PlasmaMajor topic
Adenocarcinoma, Clear Cell
Adult
Cystadenocarcinoma, Serous
Female
Follow-Up Studies
High-Throughput Nucleotide Sequencing
Humans
Longitudinal Studies
Middle Aged
Prognosis
Survival Rate

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Incheon National UniversityPubMed
2016R1D1A1B04932862National Research Foundation of KoreaPubMed

Source PubMed

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126633127SIFT missense predictions for genomes.Nat Protoc2016https://conductscience.org/library/papers/26633127PubMed
219587342Clinical practice. Screening for ovarian cancer.N Engl J Med2009https://conductscience.org/library/papers/19587342PubMed
324767708Ovarian cancer.Lancet2014https://conductscience.org/library/papers/24767708PubMed
429348365Detection and localization of surgically resectable cancers with a multi-analyte blood test.Science2018https://conductscience.org/library/papers/29348365PubMed
528468865Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology.Mol Cancer Ther2017https://conductscience.org/library/papers/28468865PubMed
615837735Frequent mutation of the PIK3CA gene in ovarian and breast cancers.Clin Cancer Res2005https://conductscience.org/library/papers/15837735PubMed
727741368Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.J Pathol2017https://conductscience.org/library/papers/27741368PubMed
830118648Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient.Cancer Biol Ther2019https://conductscience.org/library/papers/30118648PubMed
920601685ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.Nucleic Acids Res2010https://conductscience.org/library/papers/20601685PubMed
1020166213Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.Cancer2010https://conductscience.org/library/papers/20166213PubMed
1128233803Liquid biopsies come of age: towards implementation of circulating tumour DNA.Nat Rev Cancer2017https://conductscience.org/library/papers/28233803PubMed
1230422115Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13.Elife2018https://conductscience.org/library/papers/30422115PubMed
1328655895Korean Variant Archive (KOVA): a reference database of genetic variations in the Korean population.Sci Rep2017https://conductscience.org/library/papers/28655895PubMed
1426588231Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.Int J Gynecol Cancer2016https://conductscience.org/library/papers/26588231PubMed
1523396013Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.Nat Biotechnol2013https://conductscience.org/library/papers/23396013PubMed
1627997533Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.PLoS Med2016https://conductscience.org/library/papers/27997533PubMed
1730075112A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.Am J Hum Genet2018https://conductscience.org/library/papers/30075112PubMed
1823563269Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.Nature2013https://conductscience.org/library/papers/23563269PubMed
1930910306Epithelial ovarian cancer.Lancet2019https://conductscience.org/library/papers/30910306PubMed
2025851949PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels.Bioinformatics2015https://conductscience.org/library/papers/25851949PubMed

See all 28 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42435174Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer Metabolism.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435174PubMed
41602395The role of circulating tumor DNA in gynecological cancer management.Front Oncol2025https://conductscience.org/library/papers/41602395PubMed
41363274Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.Int J Cancer2026https://conductscience.org/library/papers/41363274PubMed
41327898DNA-Based Liquid Biopsy for Evaluating Surgical and Postsurgical Outcomes in Gynecologic Malignancies: A Systematic Review.J Clin Lab Anal2026https://conductscience.org/library/papers/41327898PubMed
41088281Harnessing ovarian cancer ascites for translational science: models, biomarkers, and therapeutics.Mol Cancer2025https://conductscience.org/library/papers/41088281PubMed
40340939Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40340939PubMed
40278372Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner.Metabolites2025https://conductscience.org/library/papers/40278372PubMed
40076521Circulating Tumour DNA for Ovarian Cancer Diagnosis and Treatment Monitoring: What Perspectives for Clinical Use?Int J Mol Sci2025https://conductscience.org/library/papers/40076521PubMed
40075633ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40075633PubMed
40027149Liquid biopsy into the clinics: Current evidence and future perspectives.J Liq Biopsy2024https://conductscience.org/library/papers/40027149PubMed
39201516Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges.Int J Mol Sci2024https://conductscience.org/library/papers/39201516PubMed
39115191Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer.Mol Oncol2024https://conductscience.org/library/papers/39115191PubMed
38966171Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities.Explor Target Antitumor Ther2024https://conductscience.org/library/papers/38966171PubMed
38417292Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.Transl Oncol2024https://conductscience.org/library/papers/38417292PubMed
38392306Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer.Biology (Basel)2024https://conductscience.org/library/papers/38392306PubMed
37932736Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.Mol Cancer2023https://conductscience.org/library/papers/37932736PubMed
37707677Minimal residual disease in solid tumors: an overview.Front Med2023https://conductscience.org/library/papers/37707677PubMed
37700064The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.Br J Cancer2023https://conductscience.org/library/papers/37700064PubMed
37479960Advances in application of circulating tumor DNA in ovarian cancer.Funct Integr Genomics2023https://conductscience.org/library/papers/37479960PubMed
37351260Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer.Front Physiol2023https://conductscience.org/library/papers/37351260PubMed

See all 32 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32106643

GET https://conductscience.org/api/papers/v1/32106643/references?page=2